Videos
Dana Goldman, PhD discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children's asthma medication.
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
Gaps in DSMES Understanding Persist Among Health Care Professionals, Pilot Survey Finds
3
ADA 2026: Therapeutic Inertia, Access Barriers, and the Pharmacist's Role in Closing the Cardiorenal Treatment Gap
4
Q&A: AD109 Shifts Focus in Obstructive Sleep Apnea Treatment Toward Symptom Improvement
5